Mapping the Evidence on Vitamin D, Vitamin B12, and Folate Deficiencies and Their Potential Impact on Treatment Outcomes in Patients With Cancer in Sub-Saharan Africa: Protocol for a Scoping Review.
- 1School of Pathology, Faculty of Medicine and Health Sciences, Walter Sisulu University, Sisson Street, Mthatha, Eastern Cape, South Africa, +2747 502 2204.
- 2School of Biomedical Medicines, Faculty of Medicine and Health Sciences, Walter Sisulu University, Mthatha, Eastern Cape, South Africa.
Abstract
Background
Micronutrient deficiencies, particularly of vitamin D, vitamin B12, and folate, are increasingly recognized as important, yet underexplored contributors to adverse outcomes in oncology care. These micronutrients are essential for immune regulation, DNA synthesis and repair, cell proliferation, and metabolic homeostasis, all of which are frequently disrupted in patients with cancer. Deficiencies may arise due to cancer-related metabolic changes, malabsorption, anorexia, and treatment-related toxicities, potentially influencing therapeutic response, treatment tolerance, survival, and quality of life. Despite growing evidence, findings remain fragmented across cancer types, treatment modalities, and geographical settings.Objective
This scoping review aims to systematically map the available evidence on the prevalence, determinants, and reported clinical associations of vitamin D, vitamin B12, and folate deficiencies among adult patients with cancer. The review will also explore how these deficiencies are associated with treatment-related outcomes, including toxicity, therapeutic response, survival, hospitalization, and quality of life, and will identify reported screening, supplementation, and nutritional management practices in oncology care.Methods
The review protocol follows the Joanna Briggs Institute methodology for scoping reviews and will be reported according to the PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews). A comprehensive search of PubMed and MEDLINE, Scopus, ScienceDirect, and relevant gray literature sources will be conducted for studies published between 2000 and 2025. Eligible studies will include observational, interventional, mixed methods, and qualitative studies examining vitamin D, vitamin B12, and/or folate deficiencies in adult oncology populations. Two reviewers will independently screen studies, extract data, and chart findings, whereas a third reviewer will resolve disagreements. Extracted data will include prevalence estimates, determinants of deficiencies, clinical outcomes, and nutritional management strategies. Findings will be synthesized descriptively and presented using thematic mapping, summary tables, and evidence charts.Results
A preliminary search was conducted in May 2026. Study selection commenced on June 30, 2026, following the completion of database searches and removal of duplicate records and was finalized within 8 weeks by August 30, 2026. The anticipated timelines for each stage of the review are presented in the Results section below. Preliminary search outputs from the PubMed database demonstrate the feasibility of the proposed search strategy. The final review will report the number of studies identified, screened, included, and excluded at each stage using a PRISMA-ScR flow diagram.Conclusions
The scoping review is expected to inform future systematic reviews, guide clinical research priorities, and support the integration of nutritional assessment and monitoring into personalized oncology care, particularly in resource-limited settings.
Related
- Impact of clonal hematopoiesis of indeterminate potential on treatment outcomes in multiple myeloma patients undergoing CAR-T cell therapy
- An updated meta-analysis of clinical outcomes, interventions, and treatment approaches in SMuRF vs. SMuRFless: evidence from 2.6 million ACS patients
- Association of synergistic trajectories between early mobilization potential and actual implementation with clinical outcomes among ICU patients with pneumonia: a multivariate latent class mixed model analysis
- Testosterone treatment prevents most gonadectomy-induced metabolic and skeletal deficiencies in female mice
- Survival Outcomes of Post‐Induction Treatment Strategies in Patients With Partial Response Hypopharyngeal Squamous Cell Carcinoma: A Propensity Score‐Weighted Analysis
BibTeX
@article{akapo2026mapping,
title = {{Mapping the Evidence on Vitamin D, Vitamin B12, and Folate Deficiencies and Their Potential Impact on Treatment Outcomes in Patients With Cancer in Sub-Saharan Africa: Protocol for a Scoping Review.}},
author = {Olufunmilayo Olukemi Akapo and Olubunmi Margaret Ogbodu and Teke Apalata},
journal = {JMIR research protocols},
year = {2026},
month = oct,
doi = {10.2196/91276},
url = {https://europepmc.org/article/MED/42868276},
note = {CC BY},
}
RIS
TY - JOUR
TI - Mapping the Evidence on Vitamin D, Vitamin B12, and Folate Deficiencies and Their Potential Impact on Treatment Outcomes in Patients With Cancer in Sub-Saharan Africa: Protocol for a Scoping Review.
AU - Olufunmilayo Olukemi Akapo
AU - Olubunmi Margaret Ogbodu
AU - Teke Apalata
PY - 2026
DA - 2026/10/13
JO - JMIR research protocols
DO - 10.2196/91276
UR - https://europepmc.org/article/MED/42868276
AB - Background Micronutrient deficiencies, particularly of vitamin D, vitamin B12, and folate, are increasingly recognized as important, yet underexplored contributors to adverse outcomes in oncology care. These micronutrients are essential for immune regulation, DNA synthesis and repair, cell proliferation, and metabolic homeostasis, all of which are frequently disrupted in patients with cancer. Deficiencies may arise due to cancer-related metabolic changes, malabsorption, anorexia, and treatment-related toxicities, potentially influencing therapeutic response, treatment tolerance, survival, and quality of life. Despite growing evidence, findings remain fragmented across cancer types, treatment modalities, and geographical settings.Objective This scoping review aims to systematically map the available evidence on the prevalence, determinants, and reported clinical associations of vitamin D, vitamin B12, and folate deficiencies among adult patients with cancer. The review will also explore how these deficiencies are associated with treatment-related outcomes, including toxicity, therapeutic response, survival, hospitalization, and quality of life, and will identify reported screening, supplementation, and nutritional management practices in oncology care.Methods The review protocol follows the Joanna Briggs Institute methodology for scoping reviews and will be reported according to the PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews). A comprehensive search of PubMed and MEDLINE, Scopus, ScienceDirect, and relevant gray literature sources will be conducted for studies published between 2000 and 2025. Eligible studies will include observational, interventional, mixed methods, and qualitative studies examining vitamin D, vitamin B12, and/or folate deficiencies in adult oncology populations. Two reviewers will independently screen studies, extract data, and chart findings, whereas a third reviewer will resolve disagreements. Extracted data will include prevalence estimates, determinants of deficiencies, clinical outcomes, and nutritional management strategies. Findings will be synthesized descriptively and presented using thematic mapping, summary tables, and evidence charts.Results A preliminary search was conducted in May 2026. Study selection commenced on June 30, 2026, following the completion of database searches and removal of duplicate records and was finalized within 8 weeks by August 30, 2026. The anticipated timelines for each stage of the review are presented in the Results section below. Preliminary search outputs from the PubMed database demonstrate the feasibility of the proposed search strategy. The final review will report the number of studies identified, screened, included, and excluded at each stage using a PRISMA-ScR flow diagram.Conclusions The scoping review is expected to inform future systematic reviews, guide clinical research priorities, and support the integration of nutritional assessment and monitoring into personalized oncology care, particularly in resource-limited settings.
SN - 1929-0748
ER -